9989 — Sundrug Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMid CapNeutral

Annual income statement for Sundrug Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	—	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	634,310	648,734	690,462	751,777	801,811
Cost of Revenue
Gross Profit	158,550	156,506	171,946	189,320	204,088
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	598,124	614,974	653,578	711,270	757,773
Operating Profit	36,186	33,760	36,884	40,507	44,038
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	37,188	34,675	37,710	41,261	43,569
Provision for Income Taxes
Net Income After Taxes	25,329	23,854	25,703	29,127	30,751
Net Income Before Extraordinary Items
Net Income	25,329	23,854	25,703	29,127	30,751
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	25,329	23,853	25,703	29,126	30,750
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	223	204	222	252	266
Dividends per Share